Fibrinogen receptor antagonists for inhibiting aggregation of bl

Details Fibrinogen receptor antagonists for inhibiting aggregation of bl Fibrinogen receptor antagonists for inhibiting aggregation of bl

1993-12-20

1995-10-03

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514252, 514299, 514340, 514390, 514392, 540492, 544284, 546134, 546275, 546281, 546300, 5483047, 5483235, 5483245, 5483251, A61K 31395, C07D40114

Patent

active

054552435

ABSTRACT:
Fibrinogen receptor antagonists of the formula: ##STR1## such as ##STR2## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

REFERENCES:
patent: 4064255 (1977-12-01), Champseix et al.
patent: 4122255 (1992-10-01), Krapcho
patent: 4243807 (1981-01-01), Friebe et al.
patent: 4622331 (1986-11-01), Jozie
patent: 5030654 (1991-07-01), Barnish
patent: 5064814 (1991-11-01), Klein et al.

Affiliated with

Also associated with

Rating

Fibrinogen receptor antagonists for inhibiting aggregation of bl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibrinogen receptor antagonists for inhibiting aggregation of bl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists for inhibiting aggregation of bl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1077497